Psychiatry and Psychology – Mental Disorders
The Ludwig Maximilian University Of Munich is conducting research focused on early-to-mild dementia due to Alzheimer’s disease within the broader field of Psychiatry and Psychology. Trials aim to evaluate a potential therapeutic and diagnostic role of Thiethylperazine to improve brain amyloid‑β clearance and delay cognitive decline.
- Investigating amyloid‑β clearance mechanisms
- Assessing early diagnostic biomarkers
- Exploring repurposed antipsychotic agents
- Evaluating cognitive outcomes in mild dementia
- Monitoring safety and tolerability over 12 months
A total of 6 trials involve 38 investigators, all centered at the Klinik und Poliklinik für Psychiatrie und Psychotherapie in Munich, Germany, advancing therapeutic options for patients with early Alzheimer’s pathology.
